2008 marks another record year at Yissum, the Research and Develpment Company of the Hebrew University.
Nanotechnology, employing the smallest "building blocks" man has ever used, looks set to transform all our lives, according to leaders of nanotechnology research and industry.
Van Leer Ventures Establishes Valensum to Develop the Technology, which was developmed by Professor Danny Dolev and his students from the School of Engineering and Computer Science of the Hebrew University of Jerusalem.
Based on its recent analysis of the ocular drug delivery market, Frost & Sullivan recognizes Novagali Pharma with the 2009 North American Frost & Sullivan Award for Industry Innovation & Advancement of the Year, for its two proprietary emulsion technology platforms, Novasorb and Eyeject.
Nanotechnology: Inventions of the Future By HUJI researchers Prof. Uri Banin, Prof. Shlomo Magdassi and Dr. Uriel Levy
Ms. Ben-Israel joined Yissum in 1988 and is responsible for the administration of its extensive portfolio of intellectual property from the initial invention disclosure by the researchers, through inter-institutional agreements, patent applications and prosecution and coordination of outside patent counsel activities.
Jerusalem, Israel's Capital, offers an ideal setting and financial benefits for the development of a vibrant life science industry.
To examine the various scientific and economic aspects of harnessing bioenergy, the HUJI Center for Agricultural Biotechnology, in cooperation with Yissum, will be sponsoring a symposium entitled “Bioenergy: Harnessing Plant Metabolism” Feb. 24-25, on the campus of the Hebrew University’s Faculty of Agriculture.
The Belkin-Agranat biosensor project was recently selected as one of five novel technologies receiving financing from the CleanTech fund, which supports the development of inventions with commercial potential in environmentally-friendly industries. Established by Yissum, Hebrew University's technology-transfer company, the CleanTech fund is an expression of Yissum's identification of environmental technologies as a fast emerging global megatrend.
Professor Nissim Garti from the Casali Institute of Applied Chemistry, Institute of Chemistry at the Hebrew University of Jerusalem has received the 2009 American Oil Chemists’ Society (AOCS) Stephen S. Chang Award for his invention of novel nanoparticles of structured lipids to improve the bioavailability of various drug, food or cosmetic ingredients.
With video synopsis, one day of surveillance camera footage can be condensed into a few minutes enabling real time results at significantly
Dearth of Venture Capital Spawns Innovative Actions to Invigorate Country’s Life
Hebrew University of Jerusalem's technology transfer company Yissum has just armarked $1 million dollars towards "green" technologies of the future. The money, it says, will be spent on the university's academic research towards new clean technology solutions.
Shares in the targeted cancer treatment developer are up 48%, and have nearly quadrupled in 2009.
Having to become quickly knowledgeable about something you know little about is a problem many people will be familiar with. Now Ari Rappaport at the Hebrew University of Jerusalem in Israel thinks he has a solution.
Yissum launches a $1 million program for the development of outstanding cleantech inventions by scientists at the Hebrew University of Jerusalem
Inventions of Hebrew University's Prof. Simon Benita and Yechezkel Barenholz at the forefront of innovation
Yissum, the Technology Transfer Company of the Hebrew University of Jerusalem, is launching a 1 million U.S. dollar programme to support the development of outstanding cleantech inventions by scientists at the Hebrew University of Jerusalem.
Teva will finance Jexys' R&D program for the development of a high throughput drug discovery platform and in return will receive a minority equity interest in Jexys Pharmaceuticals.